- Type
- 4
- Ref. number
- 109791-2025
- Estimated value
- 4,900,000 EUR
- CPV
- 73000000
The subject of this call for tenders is the evaluation of the immunogenicity of a booster dose, including different routes of administration (intradermal vs. subcutaneous) and the appropriate timing of the booster dose, …
for the Modified Vaccinia Ankara - Bavarian Nordic Vector (MVA-BN) vaccine. The services to be provided shall include the conduct of scientific study(s)/clinical trial(s) addressing the opinions of the CT-CM Group (Clinical Trial Coordination Mechanism subgroup of the HERA Board) on the most urgent
clinical trial needs for medical countermeasures against Mpox. In particular, the services to be contracted shall take into account the Group's advice on priority clinical trials for vaccines, the understanding of existing knowledge gaps an